MC
Merck & Co Portfolio holdings
AUM
$216M
This Quarter Return
-35.67%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$164M
AUM Growth
+$164M
(-36%)
Cap. Flow
-$1.37M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
99.69%
Holding
13
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
EVAX
Evaxion A/S American Depositary Share
EVAX
|
$1.24M |
Top Sells
| 1 |
Absci
ABSI
|
$2.62M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $65.4M | 39.83% | 2,308,190 | – | – |
|
2
Personalis
PSNL
$434M
| $49.3M | 30.01% | 14,044,943 | – | – |
|
3
Kymera Therapeutics
KYMR
$2.95B
| $21.1M | 12.86% | 772,165 | – | – |
|
4
Entrada Therapeutics
TRDA
$208M
| $15.7M | 9.57% | 1,739,768 | – | – |
|
5
Alector
ALEC
$238M
| $4.36M | 2.65% | 3,545,719 | – | – |
|
|
EVAX
6
Evaxion A/S American Depositary Share
EVAX
$17.4M
| $2.25M | 1.37% | 1,214,126 +671,847 | +124% | +$1.24M |
|
7
Sutro Biopharma
STRO
$72.7M
| $1.77M | 1.08% | 2,723,509 | – | – |
|
8
LAVA Therapeutics
LVTX
$41.3M
| $1.46M | 0.89% | 1,149,345 | – | – |
|
9
Viridian Therapeutics
VRDN
$1.5B
| $1.26M | 0.77% | 93,414 | – | – |
|
10
Xilio Therapeutics
XLO
$36.3M
| $1.07M | 0.65% | 1,483,758 | – | – |
|
11
Carisma Therapeutics
CARM
$8.98M
| $457K | 0.28% | 1,473,240 | – | – |
|
|
NEUP
12
Neuphoria Therapeutics Inc. Common Stock
NEUP
$21.3M
| $57.8K | 0.04% | 10,027 | – | – |
|
|
13
Absci
ABSI
$357M
| – | – | -998,163 | Closed | -$2.62M |
|